Overview

Detailed Summary

Aristo Bio-Tech & Lifescience Limited is an agrochemical company focused on manufacturing and supplying pesticides and agrochemicals like insecticides, herbicides, fungicides, and plant growth regulators.
The company has expanded its operations beyond its primary state to Punjab and Uttar Pradesh, demonstrating a growing geographical reach.
In 2023, Aristo Bio-Tech raised Rs. 13.05 crore through a public issue, indicating strong investor confidence and a move towards expansion.
The company engages in contract manufacturing and job work services, positioning itself as a versatile player in the agrochemical market.

Sector: Agro Chemicals
Industry: Pesticides / Agrochemicals - Indian - Medium/Small
Market Cap: 59 Cr
Volatility: Low Risk
P/E Ratio: 14.5
Industry P/E: 34.5
PEG Ratio: 0.3
P/B Ratio: 1.6
52W High: 148.00
52W Low: 86.30

Sales CAGR

1Y: 29.75%
3Y: 24.27%
5Y: 6.20%
10Y: 21.03%

Profit CAGR

1Y: 4.10%
3Y: 41.51%
5Y: 32.17%
10Y: 29.46%

ROE

TTM: 8.87%
3Y: 11.40%
5Y: 10.85%
10Y: 14.11%

ROCE

TTM: 8.61%
3Y: 16.82%
5Y: 16.43%
10Y: 20.50%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BHASKAGR	140.00	73 Cr	11.86	3.49	0.00	26.76	25.21	7.79
UNISEM	61.00	69 Cr	11.47	2.23	0.00	0.00	0.00	5.59
ARISTO	86.30	59 Cr	14.46	1.57	0.58	8.87	8.61	1.47
AMBEY	21.30	53 Cr	10.34	0.81	0.00	4.85	5.54	3.17
AIMCOPEST	48.25	47 Cr	-3.52	1.94	0.00	-41.52	-25.20	-9.65
VISHWAS	40.50	41 Cr	6.04	0.81	0.00	11.04	12.39	4.63
DHANLAXMI	24.05	39 Cr	3.67	0.85	0.00	10.08	12.38	6.71

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Half Yearly Results (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Sales	73	129	89	133	112	214	104	256
Expenses	72	124	85	128	109	206	103	249
Interest	0.94	0.77	1.98	1.02	0.68	1.02	0.64	0.98
Operating Profit	0.86	5.09	3.64	5.25	3.25	8.16	1.13	7.90
OPM %	1.18	3.94	4.10	3.95	2.89	3.81	1.09	3.08
Other Income	0.16	0.00	0.30	0.13	0.05	0.23	0.23	0.09
Depreciation	0.59	0.72	0.82	0.78	0.80	1.29	1.32	1.47
Profit Before Tax	-0.51	3.60	1.14	3.58	1.82	6.07	-0.60	5.54
Tax %	35.29	28.06	12.28	28.21	27.47	25.04	18.33	24.73
Net Profit	-0.33	2.59	1.00	2.57	1.32	4.55	-0.49	4.17
EPS in Rs	—	—	—	—	—	—	—	—

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	57	160	271	235	236	196	166	218	245	318
Expenses	56	158	264	195	197	163	161	209	237	309
Operating Profit	0.94	2.52	7.31	40	39	33	5.17	8.70	8.49	9.27
OPM %	1.64	1.58	2.69	16.97	16.47	16.93	3.12	3.99	3.46	2.92
Other Income	0.44	1.36	0.64	0.04	0.01	0.01	0.27	0.33	0.18	0.45
Interest	0.49	0.86	1.86	2.25	2.60	2.11	2.36	2.75	1.69	1.66
Depreciation	0.31	0.32	0.46	0.51	0.52	0.75	1.10	1.54	1.57	2.60
Profit Before Tax	0.59	2.70	5.63	4.10	1.40	1.50	1.98	4.74	5.41	5.47
Tax %	32.22	31.48	33.63	31.06	27.84	28.20	27.60	24.83	27.96	25.68
Net Profit	0.40	1.85	3.74	2.83	1.01	1.08	1.43	3.56	3.90	4.06
EPS in Rs	—	—	—	—	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.72	6.99	8.38

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	1.00	1.00	1.00	5.00	5.00	5.00	5.00	6.81	6.81	6.81
Reserves	1.88	3.73	7.47	6.30	7.31	8.39	9.87	23	27	31
Borrowings	4.70	10	20	14	20	22	25	22	21	22
Other Liabilities	20	72	60	65	56	46	37	47	73	81
Total Liabilities	27	87	89	91	88	81	77	100	127	141
Fixed Assets	2.11	2.11	2.63	7.91	8.26	12	14	16	22	24
CWIP	0.00	0.25	0.00	1.48	2.82	0.00	0.10	1.10	0.00	0.00
Investments	0.02	0.03	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	25	85	81	81	77	69	63	83	106	117
Total Assets	27	87	89	91	88	81	77	100	127	141

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.62	-3.97	0.85	8.15	1.41	2.28	6.78	-2.78	7.60	10
Cash from Investing Activity	-0.38	0.36	-4.78	-2.44	-2.19	-1.98	-3.16	-3.75	-6.61	-5.15
Cash from Financing Activity	-0.15	3.70	3.85	-5.77	0.87	-0.72	-3.31	7.97	-2.21	-4.39
Net Cash Flow	0.09	0.09	-0.08	-0.06	0.09	-0.41	0.30	1.44	-1.22	0.48

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Apr 2022	Jan 2023	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Promoters	100.00%	73.37%	73.37%	73.37%	73.37%	73.37%	73.42%	73.42%
FIIs	0.00%	0.05%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	0.00%	26.58%	26.63%	26.63%	26.63%	26.63%	26.58%	26.58%
Total Shareholders	7	1,004	660	652	742	625	512	468

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Aristo Bio-Tech & Lifescience Ltd

Aristo Bio-Tech & Lifescience Ltd (ARISTO) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Aristo Bio-Tech & Lifescience Limited is an agrochemical company focused on manufacturing and supplying pesticides and agrochemicals like insecticides, herbicides, fungicides, and plant growth regulators. The company has expanded its operations beyond its primary state to Punjab and Uttar Pradesh, demonstrating a growing geographical reach. In 2023, Aristo Bio-Tech raised Rs. 13.05 crore through a public issue, indicating strong investor confidence and a move towards expansion. The company engages in contract manufacturing and job work services, positioning itself as a versatile player in the agrochemical market.

Over the past 52 weeks, Aristo Bio-Tech & Lifescience Ltd has traded between a low of ₹NaN and a high of ₹NaN. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Aristo Bio-Tech & Lifescience Ltd has a market capitalization of approximately 58.75. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Aristo Bio-Tech & Lifescience Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.46 and operates in the Agro Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 58.75 Cr, Aristo Bio-Tech & Lifescience Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Aristo Bio-Tech & Lifescience Ltd operates in the Agro Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Aristo Bio-Tech & Lifescience Ltd is 14.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Aristo Bio Tech Lifescience Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Half Yearly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Aristo Bio-Tech & Lifescience Ltd

What is Aristo Bio-Tech & Lifescience Ltd share price today?

What does Aristo Bio-Tech & Lifescience Ltd do?

What is the 52-week high and low of Aristo Bio-Tech & Lifescience Ltd?

What is the market capitalization of Aristo Bio-Tech & Lifescience Ltd?

Should I consider investing in Aristo Bio-Tech & Lifescience Ltd stock?

Is Aristo Bio-Tech & Lifescience Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Aristo Bio-Tech & Lifescience Ltd belong to and why does it matter?

What is the PE ratio of Aristo Bio-Tech & Lifescience Ltd?

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Aristo Bio-Tech & Lifescience Ltd

What is Aristo Bio-Tech & Lifescience Ltd share price today?

What does Aristo Bio-Tech & Lifescience Ltd do?

What is the 52-week high and low of Aristo Bio-Tech & Lifescience Ltd?

What is the market capitalization of Aristo Bio-Tech & Lifescience Ltd?

Should I consider investing in Aristo Bio-Tech & Lifescience Ltd stock?

Is Aristo Bio-Tech & Lifescience Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Aristo Bio-Tech & Lifescience Ltd belong to and why does it matter?

What is the PE ratio of Aristo Bio-Tech & Lifescience Ltd?

Announcements

Oscillators

Neutral

Overall

Neutral

Moving Averages

Neutral

Overall

Neutral

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist